Regulatory Environment does affect Rep Employment

Discussion in 'Novartis' started by Anonymous, Jul 18, 2014 at 10:17 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Everyone knows that.
     

  2. Anonymous

    Anonymous Guest

    Does access affect Rep employment? Has access dropped in the last several years? What were the factors causing this?

    Peer pressure - other docs shunning docs that had paid access? Did the public database that tracts these paid accesses have any impact here?

    Practice Groups - many limit or deny access to reps while replacing it with standardized information and education.

    Are there other regulatory changes that impact this?
     
  3. Anonymous

    Anonymous Guest

    I think that the Sunshine Law will force a dramatic drop in access. With the dramatic rise in the use of online Doc ratings and reviews, who would want to see a Doc that could be seen as having been paid anything, even a lunch, for access?
     
  4. Anonymous

    Anonymous Guest

    How long has the implementation of the Sunshine Law been on our radar screens?
     
  5. Anonymous

    Anonymous Guest

     
  6. Anonymous

    Anonymous Guest

     
  7. Anonymous

    Anonymous Guest

    What the hell, who wrote these friggin' key information questions and why the lazy cut and paste to cafe pharma?
     
  8. Anonymous

    Anonymous Guest

     
  9. Anonymous

    Anonymous Guest

    Will the pressure to see higher quantity of patients decrease the quality of patient care?
     
  10. Anonymous

    Anonymous Guest

     
  11. Anonymous

    Anonymous Guest

     
  12. Anonymous

    Anonymous Guest

     
  13. Anonymous

    Anonymous Guest

     
  14. Anonymous

    Anonymous Guest

     
  15. Anonymous

    Anonymous Guest

    Forbes 8/20/2009 -
    Why Pharma Wants ObamaCare

    And one of the biggest forces working toward that goal is America’s biggest pharmaceutical companies, which are expected to pour as much as $150 million into advertisements supporting the reform effort.

    The only reason anybody is shocked is because they weren’t paying attention.

    http://www.forbes.com/2009/08/19/pharmaceuticals-obamacare-reform-business-healthcare-washington.html

    ABC News 6/8/2012 - Memos Unveil How White House Worked With PhRMA To Sell ObamaCare

    "Memos released Friday by the House Energy and Commerce Committee reveal the Obama administration coordinated a $150 million advertising campaign with pharmaceutical companies in support of the 2010 Affordable Care Act."

    "E-mails obtained by the Energy and Commerce Committee show that the White House traded billions of dollars in policy concessions to PhRMA for millions of dollars worth of advertising," House Speaker John Boehner, R-Ohio, said today. "The administration created and managed a super-PAC paid for by PhRMA and run by Jim Messina out of the West Wing of the White House. This is wrong and the administration must be held accountable for their actions.”

    http://abcnews.go.com/Politics/memos-unveil-how-white-house-worked-with-phrma-to-sell-obamacare/blogEntry?id=16529007&ref=https%3A%2F%2Fwww.google.com%2F

    Forbes 5/25/2013 - Obamacare Will Bring Drug Industry $35 Billion In Profits

    Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between “$10 billion and $35 billion in additional profits over the next decade,” a new analysis shows.

    The health law, which will bring millions of uninsured Americans health benefits beginning in January 2014, will be a critical boon to pharmaceutical industry balance sheets, increasing revenue by one-third by the end of the decade, according to a new report from research and consulting firm GlobalData of London. That means the U.S. pharmaceutical industry’s market value will mushroom by 33 percent to $476 billion in 2020 from $359 billion last year.

    http://www.forbes.com/sites/brucejapsen/2013/05/25/obamacare-will-bring-drug-industry-35-billion-in-profits/

    Huffington Post 5/25/11 - Obama worked cut a deal with PRMA

    "In exchange, the Pharmaceutical Researchers and Manufacturers Association (PhRMA) agreed to cut $80 billion in projected costs to taxpayers and senior citizens over ten years. Or, as the memo says: "Commitment of up to $80 billion, but not more than $80 billion.”

    RS - Annual Fee on Branded Prescription Drug Manufacturers and Importers

    Section 9008 of the Patient Protection and Affordable Care Act (ACA), Public Law 111-148 (124 Stat. 119 (2010)), as amended by section 1404 of the Health Care and Education Reconciliation Act of 2010 (HCERA), Public Law 111-152 (124 Stat. 1029 (2010)), imposes an annual fee on each covered entity engaged in the business of manufacturing or importing branded prescription drugs, to be paid not later than September 30th of each year.

    ee Year
    Applicable Amount
    2011
    $2.5 billion
    2012
    $2.8 billion
    2013
    $2.8 billion
    2014
    $3 billion
    2015
    $3 billion
    2016
    $3 billion
    2017
    $4 billion
    2018
    $4.1 billion
    2019 and thereafter
    $2.8 billion

    http://www.irs.gov/Businesses/Corporations/Annual-Fee-on-Branded-Prescription-Drug-Manufacturers-and-Importers


    And Novartis and other members of PRMA have paid for the costs of that advertising effort and these increased fees that they agreed to by laying-off, among others, Pharma Reps.

    40,000 have left the industry in since 2010. That’s about $6B in cost savings.
     
  16. Anonymous

    Anonymous Guest

     
  17. Anonymous

    Anonymous Guest

    "The health law, which will bring millions of uninsured Americans health benefits beginning in January 2014"

    - We know this wasn't true.
     
  18. Anonymous

    Anonymous Guest

     
  19. Anonymous

    Anonymous Guest

    "As this plays out, how will if affect our future?"

    How about instead of talking about how this will impact us, as if we are all passive victims, how about doing something? Take action. Don't accept the destruction of our industry.
     
  20. Anonymous

    Anonymous Guest

    The problem is that our destruction isn't seen, by anyone who matters, as destruction of the industry.

    As the article from Forbes cites above notes, Novartis and members of PRMA and Wall Street see these changes as a positive; since they have begun the stock is up and as far as future changes along these lines analysts guidance is positive. So, for that group, you seem to have failed to convince them.

    You also seem to have failed to convince every Professional Medical Organization that this is destroying our industry.

    You also seem to be losing ground within the GOP. The GOP Congress doesn't even vote to change this regulatory environment and Mitch McConnell isn't calling for changing it. In fact, he seems to try and pretend that the positive changes it brought can be embraced while pretending like to laws weren't passed.

    If you are arguing to the folks that have felt the brunt (Pharma Reps) and who will feel more as many changes play-out, you are preaching to the choir. Because, as these posts prove, Novartis and the industry has not only participated in writing these laws and regulations they have embraced them and used them to make the businesses more profitable and Wall Street is rewarding them.

    And, if you read the Forbes article and look at the trends, there will be many fewer of us in the future.